Difference between revisions of "Template:CaveQT"

Revision as of 11:03, 24 August 2009

During this switch ECG monitoring is advisable especially in patients prone to QT-conduction problems.
There is a possibilty of QT interval prolongation.^[1]

↑ Stöllberger C, Huber JO, Finsterer J, Antipsychotic drugs and QT prolongation. Int Clin Psychopharmacol. 2005 Sep;20(5):243-51.

Revision as of 11:02, 24 August 2009 (view source) Walter (talk \| contribs) ← Older edit		Revision as of 11:03, 24 August 2009 (view source) Walter (talk \| contribs) (Undo revision 3435 by Walter (Talk)) Newer edit →
Line 1:		Line 1:
	* During this switch ECG monitoring is advisable especially in patients prone to QT-conduction problems.		* During this switch ECG monitoring is advisable especially in patients prone to QT-conduction problems.
−	* There is a possibilty of QT interval prolongation.<ref> Stöllberger C, Huber JO, Finsterer J, [http://www.ncbi.nlm.nih.gov/pubmed/16096514?ordinalpos=6&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum Antipsychotic drugs and QT prolongation]. Int Clin Psychopharmacol. 2005 Sep;20(5):243-51.</ref> ~~--[[User:Walter\|Walter]] 12:02, 24 August 2009 (CEST)~~	+	* There is a possibilty of QT interval prolongation.<ref> Stöllberger C, Huber JO, Finsterer J, [http://www.ncbi.nlm.nih.gov/pubmed/16096514?ordinalpos=6&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum Antipsychotic drugs and QT prolongation]. Int Clin Psychopharmacol. 2005 Sep;20(5):243-51.</ref>